I think one thing is certain - MPL v COVID results will never be seen through to a conclusion. Why? Because MPL will be proven to be completely effective against COVID, which would then have been followed by a class action by shareholders v PAA (and if that was worthless v a particular Scottish land holder) because MPL never made it to the lucrative COVID therapeutic market.
Best to bury remarkable results not acted upon.
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-858
-
- There are more pages in this discussion • 609 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $77.79M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 16.0¢ | $95.98K | 599.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 619514 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 11.53am 22/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |